医学
腹水
失代偿
肝硬化
内科学
肝性脑病
前瞻性队列研究
肝移植
胃肠病学
入射(几何)
危险系数
比例危险模型
门脉高压
外科
移植
置信区间
物理
光学
作者
Savino Bruno,Simone Saibeni,Vincenzo Bagnardi,C. Vandelli,Massimo De Luca,Martina Felder,Anna Ludovica Fracanzani,C. Prisco,G. Vitaliani,L. Simone,Giovanni Battista Gaeta,Maria Stanzione,Marcello Persico,Caterina Furlan,Tommaso Stroffolini,Francesco Salerno,Patrick Maisonneuve,Piero Luigi Almasio
摘要
The occurrence of decompensation marks a crucial turning point in the course of cirrhosis. The purpose of this study was to assess the risk of mortality according to the clinical characteristics of first decompensation, considering also the impact of acute-on-chronic liver failure (AoCLF).We conducted a prospective nationwide inception cohort study in Italy. Decompensation was defined by the presence of ascites, either overt or detected by ultrasonography (UD), gastroesophageal variceal bleeding (GEVB), and hepatic encephalopathy (HE). AoCLF was defined according to the Asian Pacific Association for the Study of the Liver criteria. Multivariable Cox proportional hazards regression was used to analyze the risk of failure (death or orthotopic liver transplantation (OLT)).A total of 490 consecutive cirrhotic patients (314 males, mean age 60.9±12.6 years) fulfilled the study criteria. AoCLF was identified in 59 patients (12.0%). Among the remaining 431 patients, ascites were found in 330 patients (76.6%): in 257 (77.8%) as overt ascites and in 73 (22.2%) as UD ascites. GEVB was observed in 77 patients (17.9%) and HE in 30 patients (7.0%). After a median follow-up of 33 months, 24 patients underwent OLT and 125 died. The cumulative incidence of failure (death or OLT) after 1, 2, and 3 years was, respectively, 28, 53, and 62% in patients with AoCLF; 10, 18, and 25% in patients with UD ascites; 17, 31, and 41% in patients with overt ascites; and 8, 12, and 24% in patients with GEVB (P<0.0001).AoCLF is responsible for a relevant proportion of first decompensation in cirrhotic patients and is associated with the poorest outcome. Patients with UD ascites do not have a negligible mortality rate and require clinical monitoring similar to that of patients with overt ascites.
科研通智能强力驱动
Strongly Powered by AbleSci AI